Cargando…

Higher frequency of occult lymph node metastasis in clinical N0 pulmonary adenocarcinoma with ALK rearrangement

OBJECTIVES: There have been few studies that have fully elucidated the relationship between genomic mutations in pulmonary adenocarcinomas and occult lymph node (LN) metastases (pN1-2) despite a preoperative clinical N0 stage (cN0). It is well known that anaplastic lymphoma kinase (ALK) rearrangemen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seto, Katsutoshi, Kuroda, Hiroaki, Yoshida, Tatsuya, Sakata, Shozo, Mizuno, Tetsuya, Sakakura, Noriaki, Hida, Toyoaki, Yatabe, Yasushi, Sakao, Yukinori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055903/ https://www.ncbi.nlm.nih.gov/pubmed/30050322 http://dx.doi.org/10.2147/CMAR.S147569

Ejemplares similares

Successful salvage surgery following multimodal therapy in a patient who harboured ALK‐rearranged advanced lung adenocarcinoma with multiple organ metastases
por: Horio, Yoshitsugu, et al.
Publicado: (2019)

Importance of avoiding surgery delays after initial discovery of suspected non-small-cell lung cancer in clinical stage IA patients
por: Kuroda, Hiroaki, et al.
Publicado: (2018)

Efficacy of Immune Checkpoint Inhibitor Monotherapy for Advanced Non-Small-Cell Lung Cancer with ALK Rearrangement
por: Oya, Yuko, et al.
Publicado: (2020)

Spontaneous regression of lung squamous cell carcinoma with synchronous mediastinal progression: A case report
por: Matsui, Takuya, et al.
Publicado: (2018)

Prognostic significance of combined radiologic imaging modalities for prognosis of clinical IA adenocarcinomas
por: Kuroda, Hiroaki, et al.
Publicado: (2017)

Primary pneumonectomy, pneumonectomy after induction therapy, and salvage pneumonectomy: a comparison of surgical and prognostic outcomes
por: Sakakura, Noriaki, et al.
Publicado: (2020)

Lymph Node Metastases and Prognosis in Left Upper Division Non-Small Cell Lung Cancers: The Impact of Interlobar Lymph Node Metastasis
por: Kuroda, Hiroaki, et al.
Publicado: (2015)

Mediastinal pulmonary artery is associated with greater artery diameter and lingular division volume
por: Dejima, Hitoshi, et al.
Publicado: (2017)

Predictive clinical parameters for the response of nivolumab in pretreated advanced non-small-cell lung cancer
por: Oya, Yuko, et al.
Publicado: (2017)

Subsegmental resection preserves regional pulmonary function: A focus on thoracoscopy
por: Kuroda, Hiroaki, et al.
Publicado: (2021)

The Significance of the Prognostic Nutritional Index in Patients with Completely Resected Non-Small Cell Lung Cancer
por: Mori, Shunsuke, et al.
Publicado: (2015)

Prognosis and segment-specific nodal spread of primary lung cancer in the right lower lobe
por: Tomizawa, Kenji, et al.
Publicado: (2015)

Successful postoperative recovery management after thoracoscopic lobectomy and segmentectomy using an ERAS-based protocol of immediate ice cream intake and early ambulation: a 3-year study
por: Kuroda, Hiroaki, et al.
Publicado: (2019)

Selection of Pathological N0 (pN0) in Clinical IA (cIA) Lung Adenocarcinoma by Imaging Findings of the Main Tumor
por: Kanamoto, Yasuyuki, et al.
Publicado: (2020)

Imaging Characteristics of Driver Mutations in EGFR, KRAS, and ALK among Treatment-Naïve Patients with Advanced Lung Adenocarcinoma
por: Park, Jangchul, et al.
Publicado: (2016)

Radiological imaging and pathological findings of small lung adenocarcinoma: a narrative review
por: Sakao, Yukinori, et al.
Publicado: (2021)

Lymph node dissection in the left upper lobe: clinical outcomes and surgical techniques in Japan
por: Kuroda, Hiroaki, et al.
Publicado: (2019)

A Screening Method for the ALK Fusion Gene in NSCLC
por: Murakami, Yoshiko, et al.
Publicado: (2012)

Serum ProGRP and NSE levels predicting small cell lung cancer transformation in a patient with ALK rearrangement-positive non-small cell lung cancer: A case report
por: Oya, Yuko, et al.
Publicado: (2018)

A retrospective study on analgesic requirements for thoracoscopic surgery postoperative pain
por: Kuroda, Hiroaki, et al.
Publicado: (2017)

Clinical Guideline-Guided Outcome Consistency for Surgically Resected Stage III Non-Small Cell Lung Cancer: A Retrospective Study
por: Kuroda, Hiroaki, et al.
Publicado: (2021)

Targeted RNA sequencing with touch imprint cytology samples for non‐small cell lung cancer patients
por: Seto, Katsutoshi, et al.
Publicado: (2020)

The cranial-side parietal pleura pick-up method and the edge closure technique as a closure method for open thoracotomy
por: Sakakura, Noriaki, et al.
Publicado: (2020)

Anaplastic lymphoma kinase gene rearrangements in patients with advanced-stage non-small-cell lung cancer: CT characteristics and response to chemotherapy
por: Park, Jangchul, et al.
Publicado: (2014)

Resection of a ruptured mature cystic teratoma diagnosed two years after the onset of perforation
por: Kuroda, Hiroaki, et al.
Publicado: (2014)

Impact of ALK Inhibitors in Patients With ALK-Rearranged Nonlung Solid Tumors
por: Takeyasu, Yuki, et al.
Publicado: (2021)

Surgical complication and postoperative pulmonary function in patients undergoing tumor surgery with thoracic wall resection
por: Hayashi, Takuma, et al.
Publicado: (2019)

Gilteritinib overcomes lorlatinib resistance in ALK-rearranged cancer
por: Mizuta, Hayato, et al.
Publicado: (2021)

Lorlatinib Versus Pemetrexed-Based Chemotherapy in Patients With ALK-rearranged NSCLC Previously Treated With Alectinib
por: Takeyasu, Yuki, et al.
Publicado: (2022)

Phase 3 study of ceritinib vs chemotherapy in ALK-rearranged NSCLC patients previously treated with chemotherapy and crizotinib (ASCEND-5): Japanese subset
por: Kiura, Katsuyuki, et al.
Publicado: (2018)

Clinical outcomes in ALK-rearranged lung adenocarcinomas according to ALK fusion variants
por: Cha, Yoon Jin, et al.
Publicado: (2016)

ALK-rearranged squamous cell carcinoma of the lung
por: Takanashi, Yusuke, et al.
Publicado: (2015)

Endometrial cancer with an EML4-ALK rearrangement
por: Craig, Jeffrey W., et al.
Publicado: (2018)

ALK‐rearranged squamous cell carcinoma of the lung
por: Meng, Qiyi, et al.
Publicado: (2021)

Screening of ROS1 Rearrangements in Lung Adenocarcinoma by Immunohistochemistry and Comparison with ALK Rearrangements
por: Cha, Yoon Jin, et al.
Publicado: (2014)

Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK‐rearranged lung cancer
por: Yun, Mi Ran, et al.
Publicado: (2019)

An extended modification of transmanubrial osteomuscular sparing approach: salvage resection for recurrent superior sulcus lung cancer after definitive chemoradiotherapy
por: Sakakura, Noriaki, et al.
Publicado: (2021)

Alectinib for Miliary Lung Metastasis in ALK-Positive Lung Adenocarcinoma
por: Satoh, Hironori, et al.
Publicado: (2021)

Overview of ALK and ROS1 Rearranged Lung Cancer
por: Choi, Chang Min
Publicado: (2013)

Targeting ALK Rearrangements in NSCLC: Current State of the Art
por: Peng, Ling, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uebeba2ljp89nrr4ef3pit3tlf